FDA NDC Directory · JSON-LD · Markdown

Bulevirtide

NDC 65044-3633 · DRUG FOR FURTHER PROCESSING · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerJubilant HollisterStier LLC
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Active ingredientsBULEVIRTIDE ACETATE (8.5 mg/1)
Marketing started20260522
Package count1

External sources

Source: openFDA. Public-domain (CC0).